The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.

b Liverpool Health Economics Centre Liverpool University Liverpool UK

c Zem Solutions d o o Belgrade Serbia

Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute Harvard University Boston USA

e 2nd Serbian Health Project Ministry of Health Belgrade Serbia

f National Center of Research and Development of the Republic of Poland Warsaw Poland

g OAKS Consulting Czech Republic

h Institute of Management Corvinus University of Budapest Budapest Hungary

i Global Market Access Solutions Mooresville NC USA

j School of Public Policy and Administration University of Athens Athens Greece

k Division of Clinical Pharmacology Karolinska Institute Karolinska University Hospital Huddinge Stockholm Sweden

l Department of Pharmacoepidemiology Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow UK

Pharmacoeconomics Section Pharmaceutical Association of Serbia Belgrade Serbia

Citace poskytuje Crossref.org